查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1993200

自動化內視鏡再處理設備市場：2026-2032年全球市場預測（依產品類型、技術、內視鏡類型、最終用戶和通路分類）

Automated Endoscope Reprocessors Market by Product, Technology, Endoscope Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，自動化內視鏡清洗和消毒設備市場價值將達到 7.1975 億美元，到 2026 年將成長至 7.8148 億美元，到 2032 年將達到 12.4582 億美元，複合年成長率為 8.15%。

主要市場統計數據
基準年 2025 7.1975億美元
預計年份：2026年 7.8148億美元
預測年份 2032 1,245,820,000 美元
複合年成長率 (%) 8.15%

從策略觀點探討自動化內視鏡再處理系統及其在臨床安全、監管合規性和營運績效的核心角色。

自動化內視鏡清洗消毒系統是現代醫療系統感染控制策略的基礎，它提供可重複且有據可查的清洗消毒流程，從而減少人為錯誤並提高臨床診療能力。隨著檢查量的增加和監管力度的加大，決策者不再僅僅將清洗消毒系統視為資本投資，而是將其視為病人安全流程和醫療機構認證的關鍵要素。整合式系統和模組化獨立單元的引入拓寬了採購選擇，但也引發了關於生命週期成本、服務模式以及與不同內視鏡組件相容性等問題。

技術進步、更嚴格的監管以及採購重點的轉變如何重塑自動化內視鏡再處理生態系統。

在技​​術創新、監管要求不斷提高以及醫療機構採購模式轉變的推動下，自動化內視鏡再處理系統市場正經歷變革。低溫滅菌技術的進步和高水準消毒循環的改進，拓展了適用於不同類型內視鏡的選擇範圍，從而挑戰了傳統的「統一再處理」理念。因此，醫療機構既青睞能夠實現閉合迴路可追溯性的整合系統，也青睞能夠在設備多樣化的環境中柔軟性的獨立單元。

評估關稅引起的成本壓力對再加工企業供應鏈和籌資策略的連鎖影響，包括營運、採購和韌性。

2025年關稅及相關貿易措施的實施，加劇了依賴進口零件、耗材和成品再加工設備的製造商和醫療保健機構的供應鏈瓶頸。關稅導致成本上升，迫使採購團隊重新評估供應商選擇，並探索優先考慮本地供應商和垂直整合生產的替代籌資策略，以降低風險。同時，製造商也被迫重新評估其生產和分銷網路，加快關鍵製造流程的本地化進程，並對關鍵耗材和替換零件的二級供應商進行認證。

將產品類型、技術模式、臨床最終用戶、內視鏡種類和分銷管道與採購要求連結起來的多維細分分析。

細分市場洞察揭示了產品、技術、終端用戶、內視鏡類型和分銷管道趨勢如何相互作用，從而影響臨床環境中的採購決策和創新重點。就產品差異化而言，市場區分耗材和配件以及系統。系統本身包括旨在提供無縫工作流程可追溯性的整合解決方案，以及為管理不同儀器配置的機構提供模組化柔軟性的獨立單元。這種產品層面的二分法影響著採購行為。手術量大的醫院往往傾向於選擇整合式套件以集中管理文檔，而門診中心和診所則可能優先考慮獨立式解決方案，以最大限度地減少面積和資本投入。

美洲、歐洲、中東和非洲以及亞太地區的區域採用模式、監管多樣性和供應鏈趨勢塑造了戰略市場方法。

區域分析揭示了美洲、歐洲、中東和非洲以及亞太地區在部署模式、法規環境和供應鏈考量方面的差異，這些差異各自影響供應商的策略和臨床部署模式。在美洲，投資趨勢反映出醫院系統日益重視可追溯性、整合資料收集和工作流程效率，以應對大規模手術量和嚴格的認證要求。快速服務和耗材補充網路在該地區也至關重要，促使供應商優先考慮與經銷商建立牢固的關係並採用直接服務模式，以確保運作。

在整合、數位化服務、臨床協作和監管靈活性方面進行策略性企業定位，以在再處理解決方案市場中脫穎而出，領導企業。

對主要企業的分析凸顯了策略定位、服務模式和創新路徑如何使自動化內視鏡再處理系統生態系統中的市場參與企業脫穎而出。領先企業正日益追求垂直整合，以確保耗材和關鍵組件的持續供應，同時建立以快速回應、預防性保養和遠距離診斷為核心的服務網路。同時，對循環資料收集、安全日誌記錄和分析等數位化能力的投資，使主要企業能夠增強合規支持，並透過改進文件和減少再處理錯誤來展現其臨床價值。

製造商和供應商可採取的策略重點，以提高再處理的臨床價值、價值鏈韌性和商業性柔軟性。

產業領導企業應採取三管齊下的策略方法，優先考慮臨床安全、供應鏈韌性和商業性柔軟性，以最大限度地掌握再處理領域的新機會。首先，透過投資檢驗的通訊協定、完善的文件記錄能力和臨床醫生培訓項目，使產品開發和行銷與可驗證的臨床結果和簡化的合規流程保持一致。這種對臨床價值的關注有助於採購和感染控制團隊證明資本支出和營運成本的合理性，同時降低推廣阻力。

採用混合方法研究方法，結合一手訪談、第二手資料和供應鏈圖譜，以獲得實用見解，並透過專家進行迭代檢驗。

本分析的調查方法結合了質性研究、結構化的二手研究以及嚴謹的資料三角驗證，以確保研究的有效性和相關性。質性研究包括對臨床工程師、感染控制專家、採購經理和服務技術人員進行半結構式訪談，以了解門診中心、診所和醫院的營運實務和採購標準。這些訪談為特定技術的評估提供了信息，並有助於確定有關設備相容性、週期檢驗和培訓負擔等方面的實際考慮因素。

整合自動化再處理領域中臨床安全、營運韌性和供應商差異化的策略挑戰。

總之，自動化內視鏡再處理系統在病人安全、法規遵循和設施效率方面發揮著至關重要的作用。高水準消毒和低溫滅菌技術的進步正在拓展臨床應用的選擇範圍。同時，耗材、整合系統和獨立單元等產品細分為多種類型，為滿足不同的臨床需求提供了靈活的採購選擇。區域差異和關稅影響凸顯了供應鏈設計和本地支援的重要性，而那些投資於數位化可追溯性、完善的服務網路和快速回應監管要求的公司，更有能力滿足醫療服務提供者不斷變化的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：自動化內視鏡再處理設備市場：依產品分類

  • 耗材和配件
  • 系統
    • 整合式
    • 獨立型

第9章：自動化內視鏡再處理設備市場：依技術分類

  • 高水準消毒
  • 無菌
    • 高溫
    • 低溫
      • 環氧乙烷
      • 過氧化氫
      • 臭氧

第10章：以內視鏡類型分類的自動化內視鏡再處理設備市場

  • 支氣管鏡檢查
  • 胃腸內視鏡檢查
  • 泌尿科內視鏡

第11章：自動化內視鏡再處理設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章：自動化內視鏡再處理設備市場：依通路分類

  • 直銷
  • 透過分銷商銷售

第13章：自動化內視鏡再處理設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：自動化內視鏡再處理設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：自動化內視鏡再處理設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國自動化內視鏡再處理設備市場

第17章：中國自動化內視鏡再處理設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ARC Healthcare Solutions
  • Belimed AG
  • BHT Group
  • Cantel Medical Corp.
  • Choyang Medical Industry Ltd.
  • Custom Ultrasonics, Inc.
  • Getinge AB
  • Karl Storz
  • Matachana Group
  • MEDISPAs Corporation
  • Medonica Co., Ltd.
  • Metrex Research LLC
  • Nikken Medical Co., Ltd.
  • Olympus Corporation
  • Pluros GmbH
  • Shinva Medical Instrument Co., Ltd.
  • Shinva Medical Instrument Co., Ltd.
  • Soluscope SAS
  • Steelco SpA
  • STERIS plc
  • Wassenburg Medical BV
Product Code: MRR-1A1A064C0347

The Automated Endoscope Reprocessors Market was valued at USD 719.75 million in 2025 and is projected to grow to USD 781.48 million in 2026, with a CAGR of 8.15%, reaching USD 1,245.82 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 719.75 million
Estimated Year [2026] USD 781.48 million
Forecast Year [2032] USD 1,245.82 million
CAGR (%) 8.15%

A strategic orientation to automated endoscope reprocessors and their central role in clinical safety, regulatory compliance, and operational performance

Automated endoscope reprocessors have become a cornerstone of modern infection prevention strategies within healthcare systems, offering repeatable, documented cleaning and disinfection processes that reduce human variability and support clinical throughput. As procedural volumes rise and regulatory scrutiny intensifies, decision-makers increasingly view reprocessors not simply as capital equipment but as integral components of patient safety pathways and facility accreditation. The introduction of integrated systems and modular standalone units expands procurement options, yet it also raises questions about lifecycle costs, service models, and compatibility with diverse endoscope fleets.

Across clinical settings, the interplay between high-level disinfection protocols and sterilization alternatives is reshaping reprocessing workflows. Technology selection must balance device compatibility, cycle times, residual toxicity considerations, and staff training requirements. Simultaneously, the aftermarket for consumables and accessories presents an ongoing operational expenditure that influences total cost of ownership and supply chain dependency. Consequently, procurement and clinical engineering teams are aligning more closely to ensure that selection criteria include not only device efficacy but also maintenance pathways, traceability capabilities, and integration with electronic health record systems.

In sum, the introduction establishes the central role of automated endoscope reprocessors at the convergence of clinical safety, regulatory compliance, and operational efficiency. It sets the stage for deeper analysis of market drivers, segmentation dynamics, and strategic imperatives that follow in this report.

How technological advances, regulatory tightening, and evolving procurement priorities are reshaping the automated endoscope reprocessing ecosystem

The landscape for automated endoscope reprocessors is undergoing transformative shifts driven by technological innovation, heightened regulatory expectations, and shifting procurement models within healthcare delivery organizations. Advances in low-temperature sterilization chemistries and the refinement of high-level disinfection cycles have expanded viable options for diverse endoscope types, thereby challenging legacy assumptions about one-size-fits-all reprocessing. As a result, providers are evaluating integrated systems that promise closed-loop traceability alongside standalone units that offer flexibility for mixed-device fleets.

At the same time, manufacturers are prioritizing clinical usability and serviceability, integrating digital diagnostics and remote monitoring capabilities to reduce downtime and facilitate predictive maintenance. This trend is propelling partnerships between clinical engineering teams and device manufacturers, with an emphasis on interoperability and data exchange. Parallel to technology developments, regulatory frameworks and guidance documents have tightened expectations for documentation, validation, and cycle verification, prompting purchasers to demand solutions that produce auditable records and simplify compliance workflows.

Finally, the industry is witnessing a shift in procurement approaches. Buyers are increasingly weighing total cost of ownership considerations, including consumable consumption, service contracts, and training, rather than focusing solely on upfront capital costs. Together, these transformative shifts are realigning supplier priorities, accelerating innovation, and raising the bar for what healthcare institutions expect from automated reprocessing solutions.

Assessing the cascading operational, sourcing, and resilience implications of tariff-driven cost pressures on reprocessor supply chains and procurement strategies

The imposition of tariffs and related trade measures in 2025 has amplified supply chain pressure points for manufacturers and healthcare providers that depend on imported components, consumables, and finished reprocessing units. Tariff-related cost increases have forced procurement teams to reassess supplier footprints and to explore alternative sourcing strategies that prioritize regional suppliers or vertically integrated production to mitigate exposure. In parallel, manufacturers have been prompted to re-evaluate production and distribution networks, accelerating initiatives to localize critical manufacturing steps or to qualify secondary suppliers for key consumables and replacement parts.

Consequently, some organizations have adjusted inventory and spare-part strategies to buffer against lead-time variability, while others have renegotiated long-term agreements to secure more predictable pricing structures. These adaptations influence not only direct procurement costs but also the economics of service contracts, where parts availability and technician dispatch logistics determine the realized uptime of reprocessing equipment. Moreover, tariff-driven margins have placed renewed emphasis on value engineering; suppliers are investigating formulation adjustments and packaging optimizations that preserve performance while easing cross-border cost pressures.

Importantly, the tariffs have also influenced strategic collaboration patterns. Healthcare systems and original equipment manufacturers are exploring closer alignment on total lifecycle planning, from capital selection through consumable supply assurances and end-of-life management. While immediate effects center on cost and logistics, the broader consequence is an accelerated reconsideration of supply chain resilience, regional manufacturing capabilities, and procurement governance structures that will endure beyond the tariff policy window.

Multidimensional segmentation analysis linking product types, technology modalities, clinical end users, endoscope variants, and distribution channels to procurement imperatives

Segmentation insights reveal how product, technology, end-user, endoscope type, and distribution channel dynamics interplay to shape procurement decisions and innovation priorities across clinical environments. When product distinctions are considered, the market differentiates between consumables and accessories versus systems, with systems themselves spanning integrated solutions designed to provide seamless workflow traceability and standalone units that offer modular flexibility for facilities managing a heterogeneous instrumentation mix. This product-level dichotomy influences purchasing behavior: hospitals with high procedural volumes often favor integrated suites that centralize documentation, whereas ambulatory centers and clinics may prioritize standalone solutions that minimize footprint and capital outlay.

Technology segmentation further refines decision criteria through the contrast between high-level disinfection and sterilization pathways. Within sterilization, a split emerges between high-temperature steam methods and low-temperature alternatives. Steam remains the benchmark for compatible devices able to tolerate heat, but low-temperature sterilization technologies such as ethylene oxide, hydrogen peroxide, and ozone have expanded applicability to heat-sensitive endoscopes. These technology options shape both clinical protocols and lifecycle considerations, because they carry distinct validation requirements, cycle durations, residue management concerns, and environmental or occupational safety implications.

End-user segmentation underscores divergent needs among ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers frequently prioritize throughput and compact equipment footprints, clinics often seek cost-effective consumable management, and hospitals require scalable solutions that integrate across departments and maintain rigorous compliance documentation. Meanwhile, endoscope-type segmentation-covering bronchoscopes, gastrointestinal endoscopes, and urology endoscopes-drives compatibility requirements and cycle selection, since device design and materials influence susceptibility to damage and dictate permissible reprocessing chemistries. Finally, distribution channel dynamics between direct sales and distributor sales impact aftermarket support models, warranty structures, and training availability, as direct relationships may yield customized service contracts while distributor networks deliver broader geographic reach and stocking capabilities. Taken together, these segmentation lenses provide a multidimensional framework that purchasers and suppliers can use to align product capabilities with clinical and operational objectives.

Regional adoption patterns, regulatory diversity, and supply chain dynamics across the Americas, Europe Middle East & Africa, and Asia Pacific shaping strategic market approaches

Regional insights demonstrate differentiated adoption patterns, regulatory environments, and supply chain considerations across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each influencing supplier strategies and clinical deployment models. In the Americas, investment trends reflect hospital systems' emphasis on traceability, integrated data capture, and streamlined workflows to support large procedural volumes and stringent accreditation requirements. This region also prioritizes access to rapid service and consumable replenishment networks, prompting suppliers to emphasize robust distributor relationships or direct-service models to maintain uptime.

In Europe, Middle East & Africa, the market is influenced by a complex regulatory mosaic and heterogeneous purchasing power across countries. Providers in these regions often navigate layered compliance expectations and place value on validated sterilization modalities that align with national guidance, while procurement cycles can vary substantially between public and private health systems. Suppliers engaging this region frequently adopt flexible commercial models and localized support capabilities to address diverse clinical and regulatory needs. Across the Asia-Pacific region, accelerating procedural volumes and expanding surgical capacity are driving demand for scalable and cost-effective reprocessing approaches, with particular attention to technologies that balance device compatibility and consumable efficiency. Regional manufacturing and assembly centers in the Asia-Pacific also create opportunities for localized production to serve domestic demand and nearby export markets. Collectively, these regional distinctions inform go-to-market strategies, regulatory engagement plans, and investments in service infrastructure that suppliers and health systems must calibrate carefully.

Strategic corporate positioning across integration, digital services, clinical collaboration, and regulatory agility that differentiates market leaders in reprocessing solutions

Key company insights emphasize how strategic positioning, service models, and innovation pathways differentiate market participants in the automated endoscope reprocessor ecosystem. Leading organizations increasingly pursue vertical integration to secure supply continuity for consumables and critical parts while developing service networks that emphasize rapid response, preventive maintenance, and remote diagnostics. At the same time, investment in digital capabilities-such as cycle data capture, secure logging, and analytics-enables suppliers to deliver enhanced compliance support and to demonstrate clinical value through improved documentation and reduced reprocessing errors.

Moreover, strategic collaborations between device manufacturers and clinical stakeholders have become more pronounced, with co-development initiatives focused on ensuring compatibility between endoscope designs and reprocessing chemistries or cycles. Companies that cultivate strong clinical evidence packages and that transparently address validation protocols tend to gain competitive advantage during procurement evaluations. Commercially, a mix of direct sales and distributor partnerships persists, but the firms that differentiate themselves are those that can tailor service agreements and training programs to the needs of diverse end users, ranging from high-throughput hospitals to resource-constrained clinics.

Finally, organizational agility in regulatory affairs and quality systems is a critical determinant of market success. Companies that proactively engage with regulatory bodies and that maintain robust post-market surveillance programs not only reduce compliance risk but also build credibility with health systems seeking long-term partners capable of supporting evolving standards and best practices.

Actionable strategic priorities for manufacturers and providers to enhance clinical value, supply chain resilience, and commercial flexibility in reprocessing

Industry leaders should adopt a threefold strategic posture that prioritizes clinical safety, supply chain resilience, and commercial flexibility to capitalize on emerging opportunities in reprocessing. First, align product development and marketing around demonstrable clinical outcomes and compliance facilitation by investing in validated protocols, comprehensive documentation capabilities, and clinician-oriented training programs. This emphasis on clinical value helps procurement and infection prevention teams to justify capital and operational expenditures while reducing adoption friction.

Second, bolster supply chain resilience through diversified sourcing, regional manufacturing partnerships, and inventory strategies that protect against tariff impacts and logistics disruptions. Creating multiple qualified sources for critical consumables and parts, and exploring localized assembly or production where feasible, will reduce vulnerability to cross-border cost shocks and improve service responsiveness. Additionally, companies should consider modular product designs that accommodate alternative consumable formulations or interchangeable components to maintain continuity of operations.

Third, refine commercial models to offer flexible options that meet the needs of different end users. This may include bundling service and consumables, offering outcome-based maintenance agreements, or providing scalable solutions that transition from standalone units in smaller clinics to integrated systems in larger hospitals. Complement these commercial offerings with robust training and remote-support capabilities to minimize downtime and to embed suppliers as trusted clinical partners. By implementing these recommendations, industry leaders can strengthen market positioning, mitigate operational risk, and support sustained adoption across diverse healthcare settings.

A mixed methods research approach integrating primary interviews, secondary documentation, and supply chain mapping with iterative expert validation for actionable insights

The research methodology underpinning this analysis combined primary qualitative inquiry with structured secondary investigation and rigorous data triangulation to ensure validity and relevance. Primary research included semi-structured interviews with clinical engineers, infection prevention specialists, procurement leaders, and service technicians to capture operational realities and procurement criteria across ambulatory centers, clinics, and hospitals. These interviews informed technology-specific assessments and helped surface real-world considerations related to device compatibility, cycle validation, and training burdens.

Secondary research drew on regulatory guidance, published clinical standards, device labeling requirements, and manufacturer technical documentation to establish a factual foundation for technology comparisons and compliance implications. To mitigate bias and increase robustness, findings from interviews were cross-checked against multiple independent documentation sources and operational protocols. The methodology also incorporated supply chain mapping exercises to identify critical nodes, single-source dependencies, and regional manufacturing capabilities, which were then analyzed against tariff and logistics scenarios to assess resilience.

Throughout the process, analytic rigor was maintained via iterative validation sessions with subject-matter experts and clinical stakeholders. These sessions provided feedback loops that refined assumptions, clarified device-specific constraints, and ensured that recommendations were pragmatic and actionable in the context of clinical operations. The methodological approach thus balanced depth of insight with practical applicability to inform procurement, product development, and policy engagement decisions.

Synthesis of strategic imperatives for clinical safety, operational resilience, and supplier differentiation in the automated reprocessing arena

In conclusion, automated endoscope reprocessors occupy a critical intersection of patient safety, regulatory compliance, and facility efficiency. Technological advances in both high-level disinfection and low-temperature sterilization widen the set of viable clinical options, while product segmentation across consumables, integrated systems, and standalone units provides purchasing flexibility to match diverse clinical needs. Regional differences and tariff impacts underscore the importance of supply chain design and localized support, and companies that invest in digital traceability, robust service networks, and regulatory responsiveness are best positioned to meet evolving provider expectations.

Looking ahead, organizations that align product portfolios with clear clinical evidence, that diversify sourcing to reduce exposure to trade disruptions, and that offer adaptable commercial models tailored to the needs of ambulatory centers, clinics, and hospitals will create durable competitive advantage. The cumulative insights presented in this report are intended to support informed procurement choices, guide product development priorities, and enable healthcare facilities to adopt reprocessing strategies that enhance patient safety while preserving operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Endoscope Reprocessors Market, by Product

  • 8.1. Consumables And Accessories
  • 8.2. Systems
    • 8.2.1. Integrated
    • 8.2.2. Standalone

9. Automated Endoscope Reprocessors Market, by Technology

  • 9.1. High-Level Disinfection
  • 9.2. Sterilization
    • 9.2.1. High Temperature
    • 9.2.2. Low Temperature
      • 9.2.2.1. Ethylene Oxide
      • 9.2.2.2. Hydrogen Peroxide
      • 9.2.2.3. Ozone

10. Automated Endoscope Reprocessors Market, by Endoscope Type

  • 10.1. Bronchoscopes
  • 10.2. Gastrointestinal Endoscopes
  • 10.3. Urology Endoscopes

11. Automated Endoscope Reprocessors Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Automated Endoscope Reprocessors Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Automated Endoscope Reprocessors Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Automated Endoscope Reprocessors Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Automated Endoscope Reprocessors Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Automated Endoscope Reprocessors Market

17. China Automated Endoscope Reprocessors Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ARC Healthcare Solutions
  • 18.6. Belimed AG
  • 18.7. BHT Group
  • 18.8. Cantel Medical Corp.
  • 18.9. Choyang Medical Industry Ltd.
  • 18.10. Custom Ultrasonics, Inc.
  • 18.11. Getinge AB
  • 18.12. Karl Storz
  • 18.13. Matachana Group
  • 18.14. MEDISPAs Corporation
  • 18.15. Medonica Co., Ltd.
  • 18.16. Metrex Research LLC
  • 18.17. Nikken Medical Co., Ltd.
  • 18.18. Olympus Corporation
  • 18.19. Pluros GmbH
  • 18.20. Shinva Medical Instrument Co., Ltd.
  • 18.21. Shinva Medical Instrument Co., Ltd.
  • 18.22. Soluscope S.A.S.
  • 18.23. Steelco S.p.A.
  • 18.24. STERIS plc
  • 18.25. Wassenburg Medical B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HIGH-LEVEL DISINFECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HIGH-LEVEL DISINFECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HIGH-LEVEL DISINFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HIGH TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HIGH TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HIGH TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HYDROGEN PEROXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HYDROGEN PEROXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HYDROGEN PEROXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY OZONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY OZONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY OZONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY BRONCHOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY BRONCHOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY BRONCHOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY UROLOGY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY UROLOGY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY UROLOGY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 152. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 153. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GCC AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 179. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 182. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. G7 AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. NATO AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY STERILIZATION, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY LOW TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA AUTOMATED ENDOSCOPE REPROCESSORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)